https://orcid.org/0000-0001-7737-9491
References
- Arai F, Miyamoto T, Ohneda O, et al. Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-fms and receptor activator of nuclear factor kappaB (RANK) receptors. J Exp Med. 1999;190(12):1741–1754.
- Schett G, Gravallese E. Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment. Nat Rev Rheumatol. 2012;8(11):656–664.
- Hasegawa T, Kaneko Y, Izumi K, et al. Efficacy of denosumab combined with bDMARDs on radiographic progression in rheumatoid arthritis. Joint Bone Spine. 2017;84(3):379–380.
- Charles JF, Hsu L-Y, Niemi EC, et al. Inflammatory arthritis increases mouse osteoclast precursors with myeloid suppressor function. J Clin Invest. 2012;122(12):4592–4605.
- Seeling M, Hillenhoff U, David JP, et al. Inflammatory monocytes and Fcγ receptor IV on osteoclasts are critical for bone destruction during inflammatory arthritis in mice. Proc Natl Acad Sci U S A. 2013;110(26):10729–10734.
- Hasegawa T, Kikuta J, Sudo T, et al. Identification of a novel arthritis-associated osteoclast precursor macrophage regulated by FoxM1. Nat Immunol. 2019;20(12):1631–1643.
- Tanaka Y, Takeuchi T, Umehara H, et al. Safety, pharmacokinetics, and efficacy of E6011, an antifractalkine monoclonal antibody, in a first-in-patient phase 1/2 study on rheumatoid arthritis. Mod Rheumatol. 2018;28(1):58–65.
- Wakkach A, Mansour A, Dacquin R, et al. Bone marrow microenvironment controls the in vivo differentiation of murine dendritic cells into osteoclasts. Blood. 2008;112(13):5074–5083.
- Rivollier A, Mazzorana M, Tebib J, et al. Immature dendritic cell transdifferentiation into osteoclasts: a novel pathway sustained by the rheumatoid arthritis microenvironment. Blood. 2004;104(13):4029–4037.
- Ibáñez L, Abou-Ezzi G, Ciucci T, et al. Inflammatory osteoclasts prime TNFα-producing CD4+ T cells and express CX3 CR1. J Bone Miner Res. 2016;31(10):1899–1908.
- Hasegawa T, Kikuta J, Ishii M. Imaging the bone-immune cell interaction in bone destruction. Front Immunol. 2019;10:596.
- Hasegawa T, Ishii M. Visualizing bone tissue in homeostatic and pathological conditions. Proc Jpn Acad Ser B Phys Biol Sci. 2020;96(2):43–49.
- Stamatiades EG, Tremblay M-E, Bohm M, et al. Immune monitoring of trans-endothelial transport by kidney-resident macrophages. Cell. 2016;166(4):991–1003.
- Ishii M, Egen JG, Klauschen F, et al. Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis. Nature. 2009;458(7237):524–528.
- Hasegawa T, Kikuta J, Sudo T, et al. Development of an intravital imaging system for the synovial tissue reveals the dynamics of CTLA-4 Ig in vivo. Sci Rep. 2020;10(1):13480.
- Kikuta J, Wada Y, Kowada T, et al. Dynamic visualization of RANKL and Th17-mediated osteoclast function. J Clin Invest. 2013;123(2):866–873.
- Maeda H, Kowada T, Kikuta J, et al. Real-time intravital imaging of pH variation associated with osteoclast activity. Nat Chem Biol. 2016;12(8):579–585.
- Furuya M, Kikuta J, Fujimori S, et al. Direct cell–cell contact between mature osteoblasts and osteoclasts dynamically controls their functions in vivo. Nat Commun. 2018;9(1):300.
- Tomura M. New tools for imaging of immune systems: visualization of cell cycle, cell death, and cell movement by using the mice lines expressing fucci, SCAT3.1, and Kaede and KikGR. Methods Mol Biol. 2018;1763:165–174.